Titre : Extrême-Orient

Extrême-Orient : Questions médicales fréquentes

Termes MeSH sélectionnés :

Blood Component Transfusion

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une infection parasitaire en Extrême-Orient ?

Un diagnostic repose sur des tests sanguins, des analyses de selles et des antécédents de voyage.
Infections parasitaires Diagnostic médical
#2

Quels examens pour le cancer du foie en Asie ?

L'échographie, la tomodensitométrie et les tests de marqueurs tumoraux sont utilisés.
Cancer du foie Échographie
#3

Comment identifier une tuberculose en Extrême-Orient ?

Un test cutané, une radiographie pulmonaire et des cultures de crachats sont nécessaires.
Tuberculose Diagnostic médical
#4

Quels tests pour le paludisme en Asie ?

Des tests sanguins spécifiques, comme le frottis sanguin, sont utilisés pour le diagnostic.
Paludisme Diagnostic médical
#5

Comment diagnostiquer une hépatite virale ?

Des tests sanguins pour détecter les anticorps et les antigènes sont effectués.
Hépatite virale Diagnostic médical

Symptômes 5

#1

Quels sont les symptômes du choléra ?

Les symptômes incluent diarrhée aqueuse, vomissements et déshydratation rapide.
Choléra Symptômes
#2

Quels signes d'une infection par le virus Nipah ?

Fièvre, maux de tête, confusion et troubles respiratoires sont fréquents.
Virus Nipah Symptômes
#3

Quels symptômes de la dengue ?

Fièvre, douleurs articulaires, éruptions cutanées et saignements peuvent survenir.
Dengue Symptômes
#4

Quels symptômes de la grippe aviaire ?

Fièvre, toux, difficultés respiratoires et douleurs musculaires sont typiques.
Grippe aviaire Symptômes
#5

Quels signes d'une infection à Hantavirus ?

Fièvre, douleurs abdominales, et symptômes respiratoires peuvent se manifester.
Hantavirus Symptômes

Prévention 5

#1

Comment prévenir le choléra ?

L'accès à l'eau potable, l'hygiène et la vaccination sont cruciaux.
Choléra Prévention
#2

Quelles mesures pour éviter la dengue ?

Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques sont efficaces.
Dengue Prévention
#3

Comment prévenir la tuberculose ?

La vaccination BCG et le dépistage précoce des cas sont recommandés.
Tuberculose Prévention
#4

Quelles précautions pour le paludisme ?

Utiliser des moustiquaires et des médicaments prophylactiques lors de voyages à risque.
Paludisme Prévention
#5

Comment éviter l'hépatite A ?

Se laver les mains, consommer de l'eau potable et se faire vacciner sont essentiels.
Hépatite A Prévention

Traitements 5

#1

Quel traitement pour la tuberculose ?

Un traitement standard inclut des antibiotiques sur plusieurs mois, comme l'isoniazide.
Tuberculose Traitement
#2

Comment traiter le paludisme ?

Des médicaments antipaludiques comme la chloroquine ou l'artémisinine sont prescrits.
Paludisme Traitement
#3

Quel traitement pour l'hépatite B ?

Les antiviraux comme le ténofovir et l'entécavir sont souvent utilisés.
Hépatite B Traitement
#4

Comment traiter la dengue ?

Il n'existe pas de traitement spécifique ; la réhydratation et le soulagement des symptômes sont essentiels.
Dengue Traitement
#5

Quel traitement pour le choléra ?

La réhydratation orale ou intraveineuse et les antibiotiques sont essentiels.
Choléra Traitement

Complications 5

#1

Quelles complications du choléra ?

La déshydratation sévère et le choc hypovolémique peuvent être mortels.
Choléra Complications
#2

Quelles complications de la dengue ?

Le syndrome de choc dengue et les hémorragies peuvent survenir dans les cas graves.
Dengue Complications
#3

Quelles complications de l'hépatite B ?

La cirrhose et le cancer du foie sont des complications possibles à long terme.
Hépatite B Complications
#4

Quelles complications de la tuberculose ?

Les complications incluent la fibrose pulmonaire et la dissémination à d'autres organes.
Tuberculose Complications
#5

Quelles complications du paludisme ?

L'anémie sévère, l'insuffisance rénale et le coma peuvent survenir dans les cas graves.
Paludisme Complications

Facteurs de risque 5

#1

Quels sont les facteurs de risque du choléra ?

L'accès limité à l'eau potable et une mauvaise hygiène augmentent le risque.
Choléra Facteurs de risque
#2

Quels facteurs de risque pour la dengue ?

Vivre dans des zones tropicales et avoir des moustiques à proximité sont des risques.
Dengue Facteurs de risque
#3

Quels facteurs de risque pour l'hépatite A ?

Voyager dans des régions à risque et consommer des aliments contaminés augmentent le risque.
Hépatite A Facteurs de risque
#4

Quels facteurs de risque pour la tuberculose ?

La malnutrition, le VIH et le surpeuplement sont des facteurs de risque majeurs.
Tuberculose Facteurs de risque
#5

Quels facteurs de risque pour le paludisme ?

Vivre ou voyager dans des zones endémiques et ne pas utiliser de protection contre les moustiques.
Paludisme Facteurs de risque
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Extrême-Orient : Questions médicales les plus fréquentes", "headline": "Extrême-Orient : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Extrême-Orient : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-06", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Extrême-Orient" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Asie", "url": "https://questionsmedicales.fr/mesh/D001208", "about": { "@type": "MedicalCondition", "name": "Asie", "code": { "@type": "MedicalCode", "code": "D001208", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chine", "alternateName": "China", "url": "https://questionsmedicales.fr/mesh/D002681", "about": { "@type": "MedicalCondition", "name": "Chine", "code": { "@type": "MedicalCode", "code": "D002681", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hong Kong", "alternateName": "Hong Kong", "url": "https://questionsmedicales.fr/mesh/D006723", "about": { "@type": "MedicalCondition", "name": "Hong Kong", "code": { "@type": "MedicalCode", "code": "D006723", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164.450" } } }, { "@type": "MedicalWebPage", "name": "Tibet", "alternateName": "Tibet", "url": "https://questionsmedicales.fr/mesh/D018609", "about": { "@type": "MedicalCondition", "name": "Tibet", "code": { "@type": "MedicalCode", "code": "D018609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164.900" } } } ] }, { "@type": "MedicalWebPage", "name": "République démocratique populaire de Corée", "alternateName": "Democratic People's Republic of Korea", "url": "https://questionsmedicales.fr/mesh/D056911", "about": { "@type": "MedicalCondition", "name": "République démocratique populaire de Corée", "code": { "@type": "MedicalCode", "code": "D056911", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.557.500" } } }, { "@type": "MedicalWebPage", "name": "République de Corée", "alternateName": "Republic of Korea", "url": "https://questionsmedicales.fr/mesh/D056910", "about": { "@type": "MedicalCondition", "name": "République de Corée", "code": { "@type": "MedicalCode", "code": "D056910", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.557.750" } } }, { "@type": "MedicalWebPage", "name": "Mongolie", "alternateName": "Mongolia", "url": "https://questionsmedicales.fr/mesh/D008986", "about": { "@type": "MedicalCondition", "name": "Mongolie", "code": { "@type": "MedicalCode", "code": "D008986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.651" } } } ], "about": { "@type": "MedicalCondition", "name": "Extrême-Orient", "alternateName": "Asia, Eastern", "code": { "@type": "MedicalCode", "code": "D005202", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Masoud Dara", "url": "https://questionsmedicales.fr/author/Masoud%20Dara", "affiliation": { "@type": "Organization", "name": "WHO Regional Office for Europe, Copenhagen, Denmark. Electronic address: daram@who.int." } }, { "@type": "Person", "name": "Yakubu Egigogo Raji", "url": "https://questionsmedicales.fr/author/Yakubu%20Egigogo%20Raji", "affiliation": { "@type": "Organization", "name": "Department of Medical Microbiology Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "European Board and College of Obstetrics and Gynaecology (EBCOG), European Society of Contraception and Reproductive Health (ESCRH)." } }, { "@type": "Person", "name": "Tzung-Dau Wang", "url": "https://questionsmedicales.fr/author/Tzung-Dau%20Wang", "affiliation": { "@type": "Organization", "name": "Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan." } }, { "@type": "Person", "name": "Kazuomi Kario", "url": "https://questionsmedicales.fr/author/Kazuomi%20Kario", "affiliation": { "@type": "Organization", "name": "Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "How do I/we forecast tomorrows' transfusion: Blood components.", "datePublished": "2022-07-30", "url": "https://questionsmedicales.fr/article/35914702", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tracli.2022.07.006" } }, { "@type": "ScholarlyArticle", "name": "Balanced blood component resuscitation in trauma: Does it matter equally at different transfusion volumes?", "datePublished": "2022-12-15", "url": "https://questionsmedicales.fr/article/36528406", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.surg.2022.11.010" } }, { "@type": "ScholarlyArticle", "name": "Influence of the leukoreduction moment of blood components on the clinical outcomes of transfused patients in the emergency department.", "datePublished": "2024-08-26", "url": "https://questionsmedicales.fr/article/39194129", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/0034-7167-2023-0293" } }, { "@type": "ScholarlyArticle", "name": "Hypocalcemia in Trauma is Determined by the Number of Units Transfused, Not Whole Blood Versus Component Therapy.", "datePublished": "2023-05-04", "url": "https://questionsmedicales.fr/article/37148855", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jss.2023.03.043" } }, { "@type": "ScholarlyArticle", "name": "Parents' understanding and experiences of blood component transfusion in the neonatal intensive care unit: A qualitative study.", "datePublished": "2023-08-24", "url": "https://questionsmedicales.fr/article/37615240", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/apa.16952" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Asie", "item": "https://questionsmedicales.fr/mesh/D001208" }, { "@type": "ListItem", "position": 4, "name": "Extrême-Orient", "item": "https://questionsmedicales.fr/mesh/D005202" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Extrême-Orient - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Extrême-Orient", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Extrême-Orient", "description": "Comment diagnostiquer une infection parasitaire en Extrême-Orient ?\nQuels examens pour le cancer du foie en Asie ?\nComment identifier une tuberculose en Extrême-Orient ?\nQuels tests pour le paludisme en Asie ?\nComment diagnostiquer une hépatite virale ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Blood+Component+Transfusion#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Extrême-Orient", "description": "Quels sont les symptômes du choléra ?\nQuels signes d'une infection par le virus Nipah ?\nQuels symptômes de la dengue ?\nQuels symptômes de la grippe aviaire ?\nQuels signes d'une infection à Hantavirus ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Blood+Component+Transfusion#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Extrême-Orient", "description": "Comment prévenir le choléra ?\nQuelles mesures pour éviter la dengue ?\nComment prévenir la tuberculose ?\nQuelles précautions pour le paludisme ?\nComment éviter l'hépatite A ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Blood+Component+Transfusion#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Extrême-Orient", "description": "Quel traitement pour la tuberculose ?\nComment traiter le paludisme ?\nQuel traitement pour l'hépatite B ?\nComment traiter la dengue ?\nQuel traitement pour le choléra ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Blood+Component+Transfusion#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Extrême-Orient", "description": "Quelles complications du choléra ?\nQuelles complications de la dengue ?\nQuelles complications de l'hépatite B ?\nQuelles complications de la tuberculose ?\nQuelles complications du paludisme ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Blood+Component+Transfusion#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Extrême-Orient", "description": "Quels sont les facteurs de risque du choléra ?\nQuels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour l'hépatite A ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le paludisme ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Blood+Component+Transfusion#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection parasitaire en Extrême-Orient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur des tests sanguins, des analyses de selles et des antécédents de voyage." } }, { "@type": "Question", "name": "Quels examens pour le cancer du foie en Asie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie, la tomodensitométrie et les tests de marqueurs tumoraux sont utilisés." } }, { "@type": "Question", "name": "Comment identifier une tuberculose en Extrême-Orient ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un test cutané, une radiographie pulmonaire et des cultures de crachats sont nécessaires." } }, { "@type": "Question", "name": "Quels tests pour le paludisme en Asie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques, comme le frottis sanguin, sont utilisés pour le diagnostic." } }, { "@type": "Question", "name": "Comment diagnostiquer une hépatite virale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins pour détecter les anticorps et les antigènes sont effectués." } }, { "@type": "Question", "name": "Quels sont les symptômes du choléra ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée aqueuse, vomissements et déshydratation rapide." } }, { "@type": "Question", "name": "Quels signes d'une infection par le virus Nipah ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, maux de tête, confusion et troubles respiratoires sont fréquents." } }, { "@type": "Question", "name": "Quels symptômes de la dengue ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs articulaires, éruptions cutanées et saignements peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes de la grippe aviaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, toux, difficultés respiratoires et douleurs musculaires sont typiques." } }, { "@type": "Question", "name": "Quels signes d'une infection à Hantavirus ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs abdominales, et symptômes respiratoires peuvent se manifester." } }, { "@type": "Question", "name": "Comment prévenir le choléra ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'accès à l'eau potable, l'hygiène et la vaccination sont cruciaux." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la dengue ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques sont efficaces." } }, { "@type": "Question", "name": "Comment prévenir la tuberculose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination BCG et le dépistage précoce des cas sont recommandés." } }, { "@type": "Question", "name": "Quelles précautions pour le paludisme ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires et des médicaments prophylactiques lors de voyages à risque." } }, { "@type": "Question", "name": "Comment éviter l'hépatite A ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains, consommer de l'eau potable et se faire vacciner sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour la tuberculose ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement standard inclut des antibiotiques sur plusieurs mois, comme l'isoniazide." } }, { "@type": "Question", "name": "Comment traiter le paludisme ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments antipaludiques comme la chloroquine ou l'artémisinine sont prescrits." } }, { "@type": "Question", "name": "Quel traitement pour l'hépatite B ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux comme le ténofovir et l'entécavir sont souvent utilisés." } }, { "@type": "Question", "name": "Comment traiter la dengue ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique ; la réhydratation et le soulagement des symptômes sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour le choléra ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La réhydratation orale ou intraveineuse et les antibiotiques sont essentiels." } }, { "@type": "Question", "name": "Quelles complications du choléra ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation sévère et le choc hypovolémique peuvent être mortels." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le syndrome de choc dengue et les hémorragies peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Quelles complications de l'hépatite B ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La cirrhose et le cancer du foie sont des complications possibles à long terme." } }, { "@type": "Question", "name": "Quelles complications de la tuberculose ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la fibrose pulmonaire et la dissémination à d'autres organes." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'anémie sévère, l'insuffisance rénale et le coma peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du choléra ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'accès limité à l'eau potable et une mauvaise hygiène augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la dengue ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones tropicales et avoir des moustiques à proximité sont des risques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour l'hépatite A ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des régions à risque et consommer des aliments contaminés augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la tuberculose ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "La malnutrition, le VIH et le surpeuplement sont des facteurs de risque majeurs." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le paludisme ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Vivre ou voyager dans des zones endémiques et ne pas utiliser de protection contre les moustiques." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 31/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Masoud Dara

4 publications dans cette catégorie

Affiliations :
  • WHO Regional Office for Europe, Copenhagen, Denmark. Electronic address: daram@who.int.

Yakubu Egigogo Raji

3 publications dans cette catégorie

Affiliations :
  • Department of Medical Microbiology Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.
  • Department of Clinical Microbiology, College of Health Sciences, Ibrahim Badamasi Babangida University, Lapai, Nigeria.

None None

3 publications dans cette catégorie

Affiliations :
  • European Board and College of Obstetrics and Gynaecology (EBCOG), European Society of Contraception and Reproductive Health (ESCRH).

Tzung-Dau Wang

3 publications dans cette catégorie

Affiliations :
  • Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan.
Publications dans "Extrême-Orient" :

Kazuomi Kario

3 publications dans cette catégorie

Affiliations :
  • Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Publications dans "Extrême-Orient" :

Pamela S Soltis

2 publications dans cette catégorie

Affiliations :
  • Florida Museum of Natural History, University of Florida, Gainesville, FL, 32611, USA.
  • Genetics Institute, University of Florida, Gainesville, FL, 32610, USA.
  • Biodiversity Institute, University of Florida, Gainesville, FL, 32611, USA.

Douglas E Soltis

2 publications dans cette catégorie

Affiliations :
  • Department of Biology, University of Florida, Gainesville, FL, 32611, USA.
  • Florida Museum of Natural History, University of Florida, Gainesville, FL, 32611, USA.
  • Genetics Institute, University of Florida, Gainesville, FL, 32610, USA.
  • Biodiversity Institute, University of Florida, Gainesville, FL, 32611, USA.

Matthew A Gitzendanner

2 publications dans cette catégorie

Affiliations :
  • Department of Biology, University of Florida, Gainesville, FL, 32611, USA.

Xin Liu

2 publications dans cette catégorie

Ooi Peck Toung

2 publications dans cette catégorie

Affiliations :
  • Department of Veterinary Clinical Studies Faculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Malaysia.

Niazlin Mohd Taib

2 publications dans cette catégorie

Affiliations :
  • Department of Medical Microbiology Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.

Zamberi Bin Sekawi

2 publications dans cette catégorie

Affiliations :
  • Department of Medical Microbiology Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia. zamberi@upm.edu.my.

Xingya Wang

2 publications dans cette catégorie

Affiliations :
  • College of Plant Protection, Shenyang Agricultural University, Shenyang 110866, China.

Haotian Ma

2 publications dans cette catégorie

Affiliations :
  • College of Plant Protection, Shenyang Agricultural University, Shenyang 110866, China.

Yuechao Zhao

2 publications dans cette catégorie

Affiliations :
  • College of Plant Protection, Shenyang Agricultural University, Shenyang 110866, China.

Kongming Wu

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China.

Andrei Dadu

2 publications dans cette catégorie

Affiliations :
  • WHO Regional Office for Europe, Copenhagen, Denmark.

Frederick L Altice

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, 135 College Street Suite 323, New Haven, CT, 06510, USA. Frederick.Altice@yale.edu.

Alena Skrahina

2 publications dans cette catégorie

Affiliations :
  • Republican Scientific and Practical Centre for Pulmonology and TB, Minsk. alena.skrahina@gmail.com.

Vitaly Smelov

2 publications dans cette catégorie

Affiliations :
  • World Health Organization Regional Office for Europe, Copenhagen, Denmark.

Sources (10000 au total)

Balanced blood component resuscitation in trauma: Does it matter equally at different transfusion volumes?

It remains unclear whether the association between balanced blood component transfusion and lower mortality is generalizable to trauma patients receiving varying transfusion volumes. We sought to stud... Adult patients in the 2013 to 2018 American College of Surgeons Trauma Quality Improvement Program database receiving ≥6 red blood cell, ≥1 platelet, and ≥1 fresh frozen plasma within 4 hours were inc... A total of 14,549 patients were included. In patients receiving 6 to 10 units of red blood cells, red blood cell:platelet ratios were not associated with 4-hour mortality, and only red blood cell:fres... The association between balanced blood component transfusion and 4-hour mortality is not homogenous in trauma patients requiring different transfusion volumes and is specifically less evident in patie...

Influence of the leukoreduction moment of blood components on the clinical outcomes of transfused patients in the emergency department.

to investigate the influence of the leukoreduction moment (preor post-storage) of blood components on the clinical outcomes of patients transfused in the emergency department.... retrospective cohort study of patients aged 18 years or older who received preor post-storage leukoreduced red blood cell or platelet concentrate in the emergency department and remained in the instit... in a sample of 373 patients (63.27% male, mean age 54.83) and 643 transfusions (69.98% red blood cell), it was identified that the leukoreduction moment influenced the length of hospital stay (p<0.009... patients who received pre-storage leukoreduced blood components in the emergency department had a shorter length of hospital stay....

Hypocalcemia in Trauma is Determined by the Number of Units Transfused, Not Whole Blood Versus Component Therapy.

Blood component resuscitation is associated with hypocalcemia (HC) (iCal <0.9 mmol/L) that contributes to coagulopathy and death in trauma patients. It is unknown whether or not whole blood (WB) resus... This is a retrospective review of all adult trauma patients who received WB from July 2018 to December 2020. Variables included transfusions, ionized calcium levels, and calcium replacement. Patients ... Two hundred twenty-three patients received WB and met the inclusion criteria. 107 (48%) received WB only. HC occurred in 13% of patients who received more than one WB unit compared to 29% of WB and ot... HC and failure to correct HC are significant risk factors for mortality in trauma. Resuscitations with WB only and WB in combination with other blood components are associated with HC especially when ...

Parents' understanding and experiences of blood component transfusion in the neonatal intensive care unit: A qualitative study.

Blood component transfusion is a common intervention in the neonatal intensive care unit (NICU). Parents consent on their babies' behalf. This study aimed to explore parents' understandings and experi... A "low inference" qualitative descriptive semi-structured interview approach was utilised. Grounded theory was employed. Parents described their memories of babies' transfusions, their responses to th... A purposive sample of 17 parents whose babies required blood transfusion in the NICU participated. Parents talked about their initial fears of transfusion, later replaced by confidence in the process ... Parents in our study trust information from the healthcare professionals caring for their baby and would like more specific information about how blood transfusion will impact their baby, in a variety...

Blood component-associated acute transfusion reactions in pediatric patients: experience of a tertiary care hospital.

The transfusion of blood products is a life-saving clinical practice in patients with bleeding, hemoglobinopathy, and cancer. It was aimed herein to analyze the frequency and types of blood component-... This retrospective study was conducted at a tertiary care academic pediatric hospital.... During the study period, 30,811 transfusions were administered to 25,448 patients. There were 103 ATRs detected in 81 patients (0.33%; 3.34 reactions per 1000 transfusions, mean age 8.3 ± 5.98 years, ... Within our hospital, pediatric hematology-oncology wards and the stem cell transplantation unit had the most frequent ATR reports; therefore, when transfusions are carried out, increased attention sho...

Transfusion-related cost comparison of trauma patients receiving whole blood versus component therapy.

With the emergence of whole blood (WB) in trauma resuscitation, cost-related comparisons are of significant importance to providers, blood banks, and hospital systems throughout the country. The objec... A retrospective review of adult and pediatric trauma patients who received either LTO+WB or CT from time of injury to within 4 hours of arrival was performed. Annual mean cost per unit of blood produc... Prehospital LTO+WB transfusion began at this institution in January 2018. After the initiation of the WB transfusion, the mean annual cost decreased 17.3% for all blood products, and the average net d... With increased use of LTO+WB for resuscitation, cost comparison is of significant importance to all stakeholders. Low titer O+ WB was associated with reduced cost in severely injured patients. Ongoing... Therapeutic/Care Management; Level IV....

The abrogated role of premedication in the prevention of transfusion-associated adverse reactions in outpatients receiving leukocyte-reduced blood components.

Although it remains controversial, premedication before transfusion is a common clinical practice to prevent transfusion-associated adverse reactions (TAARs) in Taiwan. Thus, we aimed to investigate w... Clinical data from outpatients receiving transfusion therapy, including predisposing diseases, histories of transfusion and TAARs, premedication and the occurrence of TAARs in the period April 2017 to... A total of 5018 blood units were transfused to 803 outpatients, with 2493 transfusion events reported in the study interval. The most frequently transfused component was leukocyte-reduced packed red c... Decreased premedication was not associated with increased incidence of TAARs in outpatients; these findings provide important evidence to support the need to revise clinical practices in the era of le...

How to improve issuing, transfusion and follow-up of blood components in Southern and Eastern Mediterranean countries? A benchmark assessment.

To determine the existence of guidelines regarding the appropriate clinical use of blood and blood components, transfusion requests, and blood issuing/reception documents and procedures. The different...

Outcomes of Transfusion With Whole Blood, Component Therapy, or Both in Adult Civilian Trauma Patients: A Systematic Review and Meta-Analysis.

This systematic review and meta-analysis was conducted to compare outcomes, including transfusion volume, complications, intensive care unit length of stay, and mortality for adult civilian trauma pat... A systematic review and meta-analysis were conducted using studies that evaluated outcomes of transfusion of WB, COMP, or WB + COMP for adult civilian trauma patients. A search of PubMed, Embase, and ... This study identified an increased risk of 24-h mortality with COMP versus WB + COMP (relative risk: 1.40 [1.10, 1.78]) and increased transfusion volumes of red blood cells with COMP versus WB at 6 an... Transfusion with WB + COMP is associated with lower 24-h mortality versus COMP and transfusion with WB is associated with a lower volume of red blood cells transfused at both 6 and 24 h. Based on thes...